![Michael K. Schultz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael K. Schultz
Hoofd Techniek/Wetenschap/O&O bij PERSPECTIVE THERAPEUTICS, INC.
Actieve functies van Michael K. Schultz
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PERSPECTIVE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
Viewpoint Molecular Targeting, Inc.
![]() Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | Oprichter | 01-01-2008 | - |
Hoofd Techniek/Wetenschap/O&O | 01-08-2013 | - | |
Directeur/Bestuurslid | 01-01-2008 | - |
Loopbaan van Michael K. Schultz
Eerdere bekende functies van Michael K. Schultz
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
National Institute of Health Policy | Corporate Officer/Principal | - | - |
University of Iowa | Corporate Officer/Principal | - | - |
Statistieken
Internationaal
Verenigde Staten | 5 |
Operationeel
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Sectoraal
Consumer Services | 2 |
Commercial Services | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
PERSPECTIVE THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
National Institute of Health Policy | |
Viewpoint Molecular Targeting, Inc.
![]() Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | Commercial Services |
- Beurs
- Insiders
- Michael K. Schultz
- Ervaring